Preclinical and clinical evaluation of siddha classical drug MEDATHAARI CHOORANAM (oral administration) and CHITHIRAMOOLA TAILAM (external) in the management of JUVENILE ARTHRITIS.

Preclinical and clinical evaluation of the effect on oral administration of MEDATHAARI CHOORANAM along with external application of CHITHIRAMOOLA TAILAM in the management of BALAR KEELVAYU.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/01/039856

Enrollment

Registered

2022-01-31

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M088- Other juvenile arthritis

Interventions

Intervention1: MEDATHAARI CHOORANAM (Oral administration) : Should be administrated orally twice a day after food along with honey for 12 days.dosage : 500mg to 1 gm Intervention2: CHITHIRAMOOLA TAILA

Eligibility

Inclusion criteria

Inclusion criteria: 1.Fever 2.Pain and swelling of the joints 3.Morning stiffness 4.Rheumatoid factor positive or negative

Exclusion criteria

Exclusion criteria: 1.Children above 12 years 2.Children below 5 years 3.Rheumatic fever 4.Psoriatic arthritis 5.Gouty arthritis 6. Neurological disorders

Design outcomes

Primary

Measure	Time frame
Decreases the intensity of pain and reduce swelling of jointsTimepoint: 21 days	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr K Shyamala MD s

Government Siddha Medical College and Hospital, Palayamkottai.

shyamsujisathya@gmail.com9442277124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026